Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
rate increased » greater increase (Expand Search)
c largest » _ largest (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
c2 rate » cue rate (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
rate increased » greater increase (Expand Search)
c largest » _ largest (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
c2 rate » cue rate (Expand Search)
-
41
Image_7_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.eps
Published 2021“…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
DataSheet_1_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.docx
Published 2021“…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”
-
50
-
51
-
52
-
53
O-GlcNAc immunoprecipitation (IP) for carnitine palmitoyltransferase 1B (CPT1B).
Published 2022Subjects: -
54
-
55
-
56
-
57
-
58
-
59
Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx
Published 2025“…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”
-
60